Judith I Tsui

Summary

Publications

  1. ncbi Association of hepatitis C virus seropositivity with inflammatory markers and heart failure in persons with coronary heart disease: data from the Heart and Soul study
    Judith I Tsui
    Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine Boston Medical Center, Boston, MA 02118, USA
    J Card Fail 15:451-6. 2009
  2. ncbi Escitalopram is associated with reductions in pain severity and pain interference in opioid dependent patients with depressive symptoms
    Judith I Tsui
    Boston University School of Medicine Boston Medical Center, 801 Massachusetts Ave, Boston, MA 02118, USA
    Pain 152:2640-4. 2011
  3. ncbi Hepatitis C virus infection is associated with painful symptoms in HIV-infected adults
    Judith I Tsui
    Department of Medicine, Boston Medical Center and Boston University School of Medicine, Boston, MA, USA
    AIDS Care 24:820-7. 2012
  4. ncbi Sociodemographic trends in national ambulatory care visits for hepatitis C virus infection
    Judith I Tsui
    Division of General Internal Medicine, Department of Medicine, Boston University School of Medicine Boston Medical Center, 801 Massachusetts Ave, 2nd Floor, Boston, MA 02118, USA
    Dig Dis Sci 54:2694-8. 2009
  5. ncbi Chronic pain and hepatitis C virus infection in opioid dependent injection drug users
    Judith I Tsui
    Boston Medical Center, Boston University School of Medicine, Boston, MA 02118, USA
    J Addict Dis 30:91-7. 2011
  6. ncbi Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease
    Judith I Tsui
    Department of Medicine, University of California, San Francisco, and San Francisco General Hospital, CA 94124, USA
    Arch Intern Med 167:1271-6. 2007
  7. ncbi Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women
    Judith I Tsui
    Department of Medicine, University of California San Francisco, San Francisco, CA, USA
    Clin Infect Dis 45:736-40. 2007
  8. ncbi Risk behaviors after hepatitis C virus seroconversion in young injection drug users in San Francisco
    Judith I Tsui
    Department of Medicine, Boston University School of Medicine, Boston, MA, United States
    Drug Alcohol Depend 105:160-3. 2009

Detail Information

Publications8

  1. ncbi Association of hepatitis C virus seropositivity with inflammatory markers and heart failure in persons with coronary heart disease: data from the Heart and Soul study
    Judith I Tsui
    Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine Boston Medical Center, Boston, MA 02118, USA
    J Card Fail 15:451-6. 2009
    ..How hepatitis C virus (HCV) affects coronary heart disease (CHD) risk factors and outcomes is largely unknown...
  2. ncbi Escitalopram is associated with reductions in pain severity and pain interference in opioid dependent patients with depressive symptoms
    Judith I Tsui
    Boston University School of Medicine Boston Medical Center, 801 Massachusetts Ave, Boston, MA 02118, USA
    Pain 152:2640-4. 2011
    ..This study of opioid-dependent patients with depressive symptoms found that treatment with escitalopram was associated with clinically meaningful reductions in pain severity and pain interference during the first 3 months of therapy...
  3. ncbi Hepatitis C virus infection is associated with painful symptoms in HIV-infected adults
    Judith I Tsui
    Department of Medicine, Boston Medical Center and Boston University School of Medicine, Boston, MA, USA
    AIDS Care 24:820-7. 2012
    ..Research is needed to explore the association between HCV infection and pain, and to determine whether HCV treatment is an effective intervention...
  4. ncbi Sociodemographic trends in national ambulatory care visits for hepatitis C virus infection
    Judith I Tsui
    Division of General Internal Medicine, Department of Medicine, Boston University School of Medicine Boston Medical Center, 801 Massachusetts Ave, 2nd Floor, Boston, MA 02118, USA
    Dig Dis Sci 54:2694-8. 2009
    ..86) and patients on Medicaid vs. non-Medicaid (3.49; 1.79-6.80). Our results show that HCV-associated ambulatory care visits are increasing, with a greater proportion of visits occurring among non-white patients and Medicaid recipients...
  5. ncbi Chronic pain and hepatitis C virus infection in opioid dependent injection drug users
    Judith I Tsui
    Boston Medical Center, Boston University School of Medicine, Boston, MA 02118, USA
    J Addict Dis 30:91-7. 2011
    ..34; 95% confidence interval=0.06 to 4.62; p=0.04). Hepatitis C may be a cause for chronic pain and discomfort intolerance that is overlooked among injection drug users dependent on opioids...
  6. ncbi Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease
    Judith I Tsui
    Department of Medicine, University of California, San Francisco, and San Francisco General Hospital, CA 94124, USA
    Arch Intern Med 167:1271-6. 2007
    ..We undertook this study to determine whether having a positive HCV test result was associated with an increased risk for developing treated end-stage renal disease (ESRD)...
  7. ncbi Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women
    Judith I Tsui
    Department of Medicine, University of California San Francisco, San Francisco, CA, USA
    Clin Infect Dis 45:736-40. 2007
    ..CD4 cell counts of <200 cells/mm3 were more common among occult HBV-infected women than among those without occult HBV infection. Aminotransferase levels did not appear to be associated with being positive for HBV DNA...
  8. ncbi Risk behaviors after hepatitis C virus seroconversion in young injection drug users in San Francisco
    Judith I Tsui
    Department of Medicine, Boston University School of Medicine, Boston, MA, United States
    Drug Alcohol Depend 105:160-3. 2009
    ..This study prospectively examined young injection drug users (IDU) to determine if behaviors changed after they were made aware of HCV seroconversion...